{
  "ptid_time": "021_S_0984_2008-12-19",
  "img_path": "/data/qiuhui/data/adni/images/021_S_0984/2008-12-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 89,957 mm³, 133.5% above the reference mean. With a Z-score of 3.20 (99.9th percentile), this represents profound enlargement; hippocampal volume measures 7,556 mm³, 0.0% below the reference mean. With a Z-score of -0.00 (49.8th percentile), this represents normal volume ; whole brain volume measures 1,093,890 mm³, 1.3% above the reference mean. With a Z-score of 0.17 (56.9th percentile), this represents normal volume ; entorhinal cortex volume measures 3,469 mm³, 15.4% below the reference mean. With a Z-score of -1.04 (14.8th percentile), this represents mild atrophy; fusiform gyrus volume measures 17,690 mm³, 6.1% below the reference mean. With a Z-score of -0.52 (30.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,898 mm³, 7.3% above the reference mean. With a Z-score of 0.66 (74.4th percentile), this represents normal volume . ",
  "text_data": "Age is 78.6 years. Gender is Male. Education: 14 years. MMSE: 30.0. Logical Memory: 11.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (Z-score 3.20), which is strongly associated with neurodegeneration, but hippocampal volume is normal (Z-score -0.00). The entorhinal cortex shows mild atrophy (Z-score -1.04), while other regions are largely normal. Despite structural changes, the MMSE score of 30 is intact, suggesting no significant cognitive impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (given structural changes but preserved cognition on MMSE)  \n**Confidence:** **Medium** (ventricular enlargement and entorhinal atrophy suggest early neurodegeneration, but cognitive testing is normal, making progression uncertain).  \n\n*Note: A more sensitive cognitive test (e.g., MoCA) or longitudinal follow-up would help clarify if this represents preclinical Alzheimer’s or stable aging-related changes.*",
  "timestamp": "2025-07-26T01:35:39.404770"
}